Table 1.
Clinical characteristics of COVID-19 patients.
| Variables (n [%] or median [IQR]) | All patients (n = 309) | Non-corticosteroid (n = 220) | Corticosteroid (n = 89) | p value |
|---|---|---|---|---|
| Age (yryr) | 45.0 (33.0, 55.0) | 41.0 (32.0, 54.0) | 48.0 (36.0, 57.0) | 0.018 |
| Male | 167 (54.0) | 110 (50.0) | 57 (64.0) | 0.025 |
| Comorbidities | ||||
| Hypertension | 48 (15.5) | 31 (14.1) | 17 (19.1) | 0.271 |
| Type 2 diabetes | 25 (8.1) | 10 (4.5) | 15 (16.9) | <0.001 |
| Onset signs and symptoms | ||||
| Fever | 226 (73.1) | 143 (65.0) | 83 (93.3) | <0.001 |
| Cough | 188 (60.8) | 126 (57.3) | 62 (69.7) | 0.043 |
| Fatigue | 68 (22.0) | 44 (20.0) | 24 (27.0) | 0.181 |
| Sore throat | 34 (11.0) | 20 (9.1) | 14 (15.7) | 0.091 |
| Muscle ache | 35 (11.3) | 26 (11.8) | 9 (10.1) | 0.668 |
| Headache | 20 (6.5) | 18 (8.2) | 2 (2.2) | 0.055 |
| Days from symptom onset to admission | 5.0 (2.0, 8.0) | 5.0 (2.0, 8.0) | 5.0 (3.0, 8.0) | 0.375 |
| Laboratory and imaging findings | ||||
| WBC ( × 109/l) | 4.8 (3.8, 6.1) | 4.8 (3.8, 6.1) | 4.9 (3.7, 6.1) | 0.554 |
| Lymphocyte ( × 109/l) | 1.2 (0.9, 1.6) | 1.4 (1.0, 1.7) | 0.9 (0.7, 1.2) | <0.001 |
| ALT (U/L) | 26.0 (19.0, 37.0) | 25.0 (18.0, 37.0) | 27.0 (21.9, 40.0) | 0.05 |
| Cr (μmol/l) | 64.0 (52.0, 78.0) | 62.8 (50.1, 76.0) | 68.8 (56.5, 85.7) | 0.004 |
| PT (s) | 12.8 (12.0, 13.4) | 12.8 (12.1, 13.5) | 12.9 (12.0, 13.3) | 0.602 |
| CRP (mg/l) | 8.3 (2.3, 21.1) | 7.0 (1.7, 18.9) | 11.1 (4.1, 26.6) | 0.018 |
| Chest CT | ||||
| No pneumonia | 21 (6.8) | 20 (9.1) | 1 (1.1) | 0.012 |
| Unilateral pneumonia | 45 (14.6) | 37 (16.8) | 8 (9.0) | 0.077 |
| Bilateral pneumonia | 243 (78.6) | 163 (74.1) | 80 (90.0) | 0.002 |
IQR, interquartile range; WBC, white blood cells; ALT, alanine transaminase; Cr, creatinine; PT, prothrombin time; CRP, C-reactive protein.